Up a level |
Braconi, Daniela, Geminiani, Michela, Psarelli, Eftychia Eirini, Giustarini, Daniela, Marzocchi, Barbara, Rossi, Ranieri, Bernardini, Giulia, Spiga, Ottavia, Gallagher, James A, Kim-Hanh, Le Quan Sang et al (show 7 more authors)
(2022)
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies.
CELLS, 11 (22).
3668-.
Ranganath, Lakshminarayan R, Psarelli, Eftychia Eirini ORCID: 0000-0002-3102-0288, Arnoux, Jean-Baptiste, Braconi, Daniela, Briggs, Michael, Broijersen, Anders, Loftus, Nadia, Bygott, Helen, Cox, Trevor F, Davison, Andrew S ORCID: 0000-0001-5501-4475 et al (show 39 more authors)
(2020)
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.
The Lancet Diabetes and Endocrinology, 8 (9).
pp. 762-772.
Rai, Zainab L, Ranieri, Veronica, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Littler, Peter, Ghaneh, Pauleh, Gurusamy, Kurinchi, Manas, Derek, Pizzo, Elena, Psarelli, Eftychia Eirini, Gilmore, Roopinder et al (show 4 more authors)
(2022)
Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial.
BMJ OPEN, 12 (5).
e050166-.